Member access

4-Traders Homepage  >  Shares  >  Nyse  >  Par Pharmaceutical Companies, Inc.    PRX   US69888P1066

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsForum 
Company
More about the company
Chart PAR PHARMACEUTICAL COMPANI
Duration : Period :
Par Pharmaceutical Compani Technical Analysis Chart | PRX | US69888P1066 | 4-Traders
Full-screen chart
Latest news on PAR PHARMACEUTICAL COMPANI
01/18 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Gener..
01/02 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Rizat..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Gener..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Begins Shipment of Gener..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Acquires Rights To Marke..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Receives Final Approval ..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Announces Completion Of Acquisition By ..
2012DJADT, Pentair to Gain Spots on S&P 500, Replacing Lexmark, DeVry
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Par Pharmaceutical Companies Announces The ..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Robbins Geller Rudman & Dowd LLP Files Clas..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Ryan & Maniskas, LLP Announces Investigatio..
2012 PAR PHARMACEUTICAL COMPANIES, INC.: Law Offices of Todd M. Garber Announces Inv..
More news
Forum PAR PHARMACEUTICAL COMPANI
Advertisement
Income Statement Evolution
Par Pharmaceutical Compani : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF
Copyright © 2013 Surperformance. All rights reserved.